Learning objectives for this Grand Rounds course include reviewing routes of administration, outcomes and adverse events related to ocular gene therapy.
Brittni A. Scruggs, M.D., Ph.D., an ophthalmic surgeon at Mayo Clinic in Rochester, Minnesota, reviews routes of administration and discusses outcomes and adverse events related to ocular gene therapy.
